These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8821048)

  • 21. Novel potent sigma 1 ligands: N-[omega-(tetralin-1-yl)alkyl]piperidine derivatives.
    Berardi F; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1996 Oct; 39(21):4255-60. PubMed ID: 8863803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-methyl-D-aspartate and sigma-ligands change the production of interleukins 8 and 10 in lymphocytes through modulation of the NMDA glutamate receptor.
    Kvaratskhelia E; Maisuradze E; Dabrundashvili NG; Natsvlishvili N; Zhuravliova E; Mikeladze DG
    Neuroimmunomodulation; 2009; 16(3):201-7. PubMed ID: 19246943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel sigma receptor ligands: synthesis and biological profile.
    Prezzavento O; Campisi A; Ronsisvalle S; Li Volti G; Marrazzo A; Bramanti V; Cannavò G; Vanella L; Cagnotto A; Mennini T; Ientile R; Ronsisvalle G
    J Med Chem; 2007 Mar; 50(5):951-61. PubMed ID: 17328523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related changes in the N-methyl-D-aspartate receptor binding sites within the human basal ganglia.
    Villares JC; Stavale JN
    Exp Neurol; 2001 Oct; 171(2):391-404. PubMed ID: 11573991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex.
    Berger ML; Rebernik P
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiosynthesis and pharmacological evaluation of [11C]EMD-95885: a high affinity ligand for NR2B-containing NMDA receptors.
    Roger G; Dollé F; De Bruin B; Liu X; Besret L; Bramoullé Y; Coulon C; Ottaviani M; Bottlaender M; Valette H; Kassiou M
    Bioorg Med Chem; 2004 Jun; 12(12):3229-37. PubMed ID: 15158791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors.
    Debonnel G; Bergeron R; de Montigny C
    J Endocrinol; 1996 Sep; 150 Suppl():S33-42. PubMed ID: 8943785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
    Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
    Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple mechanisms of action: the pharmacological profile of budipine.
    Eltze M
    J Neural Transm Suppl; 1999; 56():83-105. PubMed ID: 10370904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anticonvulsant actions of sigma receptor ligands in the Mg2+-free model of epileptiform activity in rat hippocampal slices.
    Thurgur C; Church J
    Br J Pharmacol; 1998 Jul; 124(5):917-29. PubMed ID: 9692777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of glycine binding site of N-methyl-D-asparate receptors in living human brain using 4-acetoxy derivative of L-703,717, 4-acetoxy-7-chloro-3-[3-(4-[11c] methoxybenzyl) phenyl]-2(1H)-quinolone (AcL703) with positron emission tomography.
    Matsumoto R; Haradahira T; Ito H; Fujimura Y; Seki C; Ikoma Y; Maeda J; Arakawa R; Takano A; Takahashi H; Higuchi M; Suzuki K; Fukui K; Suhara T
    Synapse; 2007 Oct; 61(10):795-800. PubMed ID: 17598152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and NMDA-receptor affinity of ring and side chain homologous dexoxadrol derivatives.
    Aepkers M; Wünsch B
    Arch Pharm (Weinheim); 2004 Feb; 337(2):67-75. PubMed ID: 14981662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From NMDA receptor antagonists to discovery of selective σ₂ receptor ligands.
    Gitto R; De Luca L; Ferro S; Scala A; Ronsisvalle S; Parenti C; Prezzavento O; Buemi MR; Chimirri A
    Bioorg Med Chem; 2014 Jan; 22(1):393-7. PubMed ID: 24290063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Budipine and the MPTP binding site.
    Przuntek H; Russ H
    Lancet; 1985 Jul; 2(8445):35-6. PubMed ID: 2861470
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical efficacy of budipine in Parkinson's disease.
    Przuntek H; Müller T
    J Neural Transm Suppl; 1999; 56():75-82. PubMed ID: 10370903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolic fate of the anti-parkinsonian drug budipine in rats.
    Caputo O; Grosa G; Ceruti M; Rocco F; Biglino G
    Eur J Drug Metab Pharmacokinet; 1991; 16(2):113-8. PubMed ID: 1936070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-dopaminergic therapy in Parkinson's disease.
    Przuntek H
    J Neurol; 2000 Apr; 247 Suppl 2():II19-24. PubMed ID: 10991661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing the proposed phenyl-A region of the sigma-1 receptor.
    Ablordeppey SY; Fischer JB; Law H; Glennon RA
    Bioorg Med Chem; 2002 Aug; 10(8):2759-65. PubMed ID: 12057665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic brain concentration of the NMDA receptor antagonist amantadine.
    Kornhuber J; Quack G; Danysz W; Jellinger K; Danielczyk W; Gsell W; Riederer P
    Neuropharmacology; 1995 Jul; 34(7):713-21. PubMed ID: 8532138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.